Meet Nancy from Winnipeg, a resilient wife and mother who faced triple-positive breast cancer, a subtype accounting for 10% of all breast cancer diagnoses.

Triple-positive breast cancer, characterized by positive tests for estrogen receptors, progesterone receptors, and elevated HER2 protein levels, poses unique challenges. Nancy’s journey included chemotherapy, a single mastectomy with immediate reconstruction, Herceptin and Kadcyla infusions, radiation treatments, and medically induced menopause.

Nancy shared, « Completing my active treatment in November marked the end of a phase, but my journey continues with Exemestane and Zoladex hormone therapy and preventative medications, Nerlynx and Zoledronic Acid. These treatments are backed by clinical studies and have shown promising results in survival rates. This was significant to me as I reviewed my options. »

Amidst her journey, Nancy’s three supportive children supported fundraisers, raising funds and fostering awareness about cancer in their Manitoba community. Her oldest son and daughter’s teams even featured Nancy as a guest of honour at their events.

Reflecting on her story, Nancy shares the importance of breast and self-advocacy.

Detecting an indent in her left breast at the age of 42, she emphasizes, « Advocating for screening is crucial. This was the start of my journey. Sitting in the exam room and explaining the dimple — no lump and no family history of breast cancer. I was examined at my family doctor’s office and referred me for a mammogram. I needed that mammogram, defying the routine age norm of 50 in Manitoba. »

Nancy encourages individuals to inquire about participating in clinical trials exploring novel breast cancer treatments.

Her story holds a narrative around the powerful testament of research, clinical trials, and the relentless pursuit of to end breast cancer.